- Home
- LIDR vs AIMD Comparison
LIDR vs AIMD Comparison
Compare LIDR & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- AIMD
- Stock Information
- Founded
- LIDR 2013
- AIMD 1984
- Country
- LIDR United States
- AIMD United States
- Employees
- LIDR N/A
- AIMD N/A
- Industry
- LIDR Auto Parts:O.E.M.
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- LIDR Consumer Discretionary
- AIMD Health Care
- Exchange
- LIDR Nasdaq
- AIMD Nasdaq
- Market Cap
- LIDR 9.8M
- AIMD 9.9M
- IPO Year
- LIDR N/A
- AIMD N/A
- Fundamental
- Price
- LIDR $0.70
- AIMD $0.55
- Analyst Decision
- LIDR Hold
- AIMD
- Analyst Count
- LIDR 1
- AIMD 0
- Target Price
- LIDR N/A
- AIMD N/A
- AVG Volume (30 Days)
- LIDR 194.5K
- AIMD 198.1K
- Earning Date
- LIDR 05-08-2025
- AIMD 05-12-2025
- Dividend Yield
- LIDR N/A
- AIMD N/A
- EPS Growth
- LIDR N/A
- AIMD N/A
- EPS
- LIDR N/A
- AIMD N/A
- Revenue
- LIDR $202,000.00
- AIMD $20,729.00
- Revenue This Year
- LIDR $2,677.23
- AIMD N/A
- Revenue Next Year
- LIDR $409.09
- AIMD N/A
- P/E Ratio
- LIDR N/A
- AIMD N/A
- Revenue Growth
- LIDR N/A
- AIMD N/A
- 52 Week Low
- LIDR $0.49
- AIMD $0.40
- 52 Week High
- LIDR $5.15
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- LIDR 59.40
- AIMD 52.13
- Support Level
- LIDR $0.61
- AIMD $0.52
- Resistance Level
- LIDR $0.68
- AIMD $0.59
- Average True Range (ATR)
- LIDR 0.05
- AIMD 0.05
- MACD
- LIDR 0.02
- AIMD 0.00
- Stochastic Oscillator
- LIDR 79.80
- AIMD 50.00
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.